FdaApplication

ANDA 215913

Back to search

Identifiers

Properties

PropertyValue
applicant_nameZENARA PHARMA PRIVATE LTD
application_typeANDA
approval_date2025-06-13

Products (2)

ProductActive ingredientStrengthDosage form
SAFINAMIDE MESYLATESAFINAMIDE MESYLATEEQ 100MG BASETABLET;ORAL
SAFINAMIDE MESYLATESAFINAMIDE MESYLATEEQ 50MG BASETABLET;ORAL

2 products